BackOpus Genetics Overview

Opus Genetics Long Term Debt

Track Opus Genetics's long-term debt ($35M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$34.53M

Peer trimmed avg / median

Loading

Opus Genetics Long Term Debt History

Loading

Opus Genetics vs. peers: Long Term Debt Comparison

Loading

Opus Genetics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Opus Genetics (IRD) FAQ

Opus Genetics (IRD) currently reports a long-term debt of $35M as of September 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Opus Genetics's long-term debt history and peer comparisons.

Opus Genetics's long-term debt changed from $0 to $35M (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Opus Genetics reported $35M in long-term debt as of September 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Opus Genetics, and consider following IRD for alerts when major investors trade the stock.

Opus Genetics is classified in the Healthcare sector. On long-term debt, it currently shows $35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IRD with unrelated industries.